Drug · DIN 02426897
APTIOM
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 30, 2026; first marketed August 7, 2014.
- Drug Identification Number (DIN)
- 02426897
- Company (DIN owner)
- Sumitomo Pharma Canada, Inc.Mississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Eslicarbazepine N03AF04
- Class
- Human
- Record last updated
- July 2, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ESLICARBAZEPINE ACETATE | 800 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 25, 2024: NOC 32597New Drug Submission (NDS) · Administrative: Manufacturer Name Change
- July 8, 2014: NOC 15782New Drug Submission (NDS)
Other DINs named APTIOM
- DIN 02426862 · Cancelled Post Market
- DIN 02426870 · Cancelled Post Market
- DIN 02426889 · Cancelled Post Market